Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Ribelli

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Scientific Reports|August 23, 2017
Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysisFrancesca R Bertani, Pamela Mozetic, Marco Fioramonti, et al.
Expert Opinion on Biological Therapy|August 25, 2020
Denosumab for cancer-related bone lossEmanuela Dell'Aquila, Grazia Armento, Michele Iuliani, et al.
Oncotarget|April 24, 2015
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironmentMichele Iuliani, Francesco Pantano, Consuelo Buttigliero, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 29, 2020
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samplesMarco Russano, Andrea Napolitano, Giulia Ribelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 26, 2020
Correction to: Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samplesMarco Russano, Andrea Napolitano, Giulia Ribelli, et al.
Oncogene|January 9, 2021
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesionsFrancesco Pantano, Martine Croset, Keltouma Driouch, et al.
Cancers|May 28, 2022
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer PatientsFrancesco Pantano, Francesca Zalfa, Michele Iuliani, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Scientific Reports|August 23, 2017
Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysisFrancesca R Bertani, Pamela Mozetic, Marco Fioramonti, et al.
Expert Opinion on Biological Therapy|August 25, 2020
Denosumab for cancer-related bone lossEmanuela Dell'Aquila, Grazia Armento, Michele Iuliani, et al.
Oncotarget|April 24, 2015
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironmentMichele Iuliani, Francesco Pantano, Consuelo Buttigliero, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 29, 2020
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samplesMarco Russano, Andrea Napolitano, Giulia Ribelli, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 26, 2020
Correction to: Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samplesMarco Russano, Andrea Napolitano, Giulia Ribelli, et al.
Oncogene|January 9, 2021
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesionsFrancesco Pantano, Martine Croset, Keltouma Driouch, et al.
Cancers|May 28, 2022
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer PatientsFrancesco Pantano, Francesca Zalfa, Michele Iuliani, et al.
Pageof 2